• A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm
• Abnormal spontaneous neural activity of brain regions in patients with primary blepharospasm at rest
• Abnormal supplementary motor areas are associated with idiopathic and acquired blepharospasm
• An Exploratory, Randomized, Double-Blind Clinical Trial of Dipraglurant for Blepharospasm
• Anatomical categorization of isolated non-focal dystonia: novel and existing patterns using a data-driven approach
• Antibody Development in Patients Treated Long-Term With OnabotulinumtoxinA for Benign Essential Blepharospasm and Hemifacial Spasm
• Application of colored filters in patients post-traumatic brain injury: A review
• Basis of movement control in dystonia and why botulinum toxin should influence it?
• Benign Essential Blepharospasm
• Benign Essential Blepharospasm
• Blepharospasm, dry eye and extractable nuclear antigen antibodies
• Blepharospasm, dry eye and extractable nuclear antigen antibodies (French translation of the article)
• Blepharospasm: Is it really a "Benign" or an "Essential" Condition?
• Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach
• Botulinum toxin injection and tear production
• Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm
• Characteristics of tear abnormalities associated with benign essential blepharospasm and amelioration by means of botulinum toxin type A treatment
• Chemodenervation for the Treatment of Facial Dystonia: A Report by the American Academy of Ophthalmology
• Clinical Features of Benign Essential Blepharospasm in Korean Patients
• Clinical study of patients with benign essential blepharospasm and hemifacial spasm
• Combined effects of rTMS and botulinum toxin therapy in benign essential blepharospasm
• Comparison of automated and manual quantification methods for neuromelanin-sensitive MRI in Parkinson's disease
• Comparison of Safety and Efficacy of Botox and Neuronox in the Management of Benign Essential Blepharospasm: A Split-face Study
• Complications of Preseptal Versus Pretarsal Botulinum Toxin Injection in Benign Essential Blepharospasm: A Randomized Controlled Trial
• Developments in the treatment of benign essential blepharospasm
• Diagnosis of primary hemifacial spasm
• Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
• Disabling muscle of Riolan: A novel concept of orbicularis oculi myectomy for refractory benign essential blepharospasm
• Disease modifying treatment trials in Parkinson's disease: how to balance expectations and interests of patients, physicians and industry partners?
• Dry eye and qualitative tear alteration in essential blepharospasm
• Dry eye disease and blinking behaviors: A narrative review of methodologies for measuring blink dynamics and inducing blink response
• Dry eye syndrome in benign essential blepharospasm
• Duration of botulinum toxin efficacy in cervical dystonia clinical trials: A scoping review
• Effect of Botulinum Toxin A Treatment on Eyelid Pressure in Eyes with Blepharospasm
• Effectiveness of 0.3% Hyaluronic Acid Eye Drops for Benign Essential Blepharospasm and Hemifacial Spasm with Botulinum Toxin-induced Dry Eye
• Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm
• Efficacy of CT-guided partial radiofrequency ablation of bilateral responsible cranial nerves in the treatment of Meige syndrome
• Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
• Epidemiology of benign essential blepharospasm: A nationwide population-based retrospective study in Taiwan
• Evaluation of ocular blood flow by Doppler ultrasound in patients with essential blepharospasm
• Eye pain in the white and quiet eye
• Frequency of Hemorrhagic Side Effects of Botulinum Neurotoxin Treatment in Patients with Blepharospasm and Hemifacial Spasm on Antithrombotic Medication
• Genetic Screening of a Hungarian Cohort with Focal Dystonia Identified Several Novel Putative Pathogenic Gene Variants
• Glucose hypometabolism in the visual cortex proportional to disease severity in patients with essential blepharospasm
• Health-related quality of life of daily-life-affected benign essential blepharospasm: Multi-center observational study
• Histopathological View of Benign Essential Blepharospasm: Orbicularis Oculi Hormone Receptor Levels
• Imaging of dopamine transporters in Parkinson disease: a meta-analysis of ¹⁸ F/¹²³ I-FP-CIT studies
• Impact of Upper Eyelid Surgery on Symptom Severity and Frequency in Benign Essential Blepharospasm
• Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm
• Increased pupillary constriction velocity in benign essential blepharospasm associated with photophobia
• Injecting botulinum toxin into the treatment of blepharospasm
• Is deep brain stimulation therapy underutilized for movement disorders?
• Long-term Efficacy of Bilateral Globus Pallidus Stimulation in the Treatment of Meige Syndrome
• Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm
• Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia
• Long-term stable efficacy of botulinum toxin A in facial movement disorders with no need for increasing dose
• Longitudinal predictors of health-related quality of life in isolated dystonia
• Medical and Surgical Treatments for Dystonia
• Medical cannabis oil for benign essential blepharospasm: a prospective, randomized controlled pilot study
• Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation
• Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases
• Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis
• Myotomy In Situ for Essential Blepharospasm Refractory to Botulinum Toxin
• Oromandibular Dystonia: A Clinical Examination of 2,020 Cases
• Outcome of Injection Botulinum Toxin in Blepharospasm
• Outcomes of a regional variant of botulinum toxin type A in the treatment of essential blepharospasm and hemifacial spasms: A retrospective study
• Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
• Parkinson's disease cerebrovascular reactivity pattern: A feasibility study
• Patient-reported outcomes following a break in ophthalmic botulinum toxin therapy during the COVID-19 pandemic
• Personality profile of the primary blepharospasm (BSP): An investigation using the Minnesota Multiphasic Personality Inventory
• Physiological effects of subthalamic nucleus deep brain stimulation surgery in cervical dystonia
• Possible role of frankincense in the treatment of benign essential blepharospasm
• Profile of patients with essential blepharospasm and hemifacial spasm in the two largest ophthalmology reference centers in Brazil
• Quality of life in idiopathic dystonia: a systematic review
• Quality of life in isolated dystonia: non-motor manifestations matter
• Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease
• Relations between nonmotor manifestations and motor disorders in patients with benign essential blepharospasm
• Retracted: Serum Metabolomics of Benign Essential Blepharospasm Using Liquid Chromatography and Orbitrap Mass Spectrometry
• Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease: A Systematic Review and Meta-analysis
• Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study
• Screening Gene Mutations in Chinese Patients With Benign Essential Blepharospasm
• Sensory Trick Frames: A New Device for Blepharospasm Patients
• Serum calcium, magnesium, phosphorus, and vitamin D in benign essential blepharospasm
• Serum Metabolomics of Benign Essential Blepharospasm Using Liquid Chromatography and Orbitrap Mass Spectrometry
• Sex, blinking, and dry eye
• Smartphone and custom-made software to assess the effect of botulinum toxin in essential blepharospasm: Initial results
• Stroke-induced resolution of primary blepharospasm: evidence for the lenticular nucleus as a control candidate
• Surgical approach to limiting skin contracture following protractor myectomy for essential blepharospasm
• Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm
• THE EFFECT OF BOTULINUM TOXIN TYPE A IN PATIENTS WITH ESSENTIAL BLEPHAROSPASM
• The effect on blink frequency of a selective blue-filtering photochromic lens in patients with benign essential blepharospasm
• The global prevalence of human fascioliasis: a systematic review and meta-analysis
• The good toxin: 10 years of experience with botulinum toxin A in the treatment of benign essential blepharospasm
• Therapy of Benign Essential Blepharospasm with Botulinum Toxin
• Translation, adaptation, and cross-cultural validation of the CDQ-24 scale in patients with primary blepharospasm under botulinum toxin treatment, pilot test
• Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A-30 Years of Experience in a Tertiary Care Center
• Validation of a New Patient-Reported Outcome Measure of the Functional Impact of Essential Tremor on Activities of Daily Living
• Voxel-Wise Brain-Wide Functional Connectivity Abnormalities in Patients with Primary Blepharospasm at Rest
• Which factors impact on quality of life for adults with blepharospasm and hemifacial spasm?
• White Matter Hyperintensities Are Associated With Severity of Essential Tremor in the Elderly